Corrigendum to “Post Hoc Analysis of a Phase 2 Randomized Trial of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease: Associations With Platelet Count, Liver Stiffness, and Spleen Volume” [J Clin Exp Hepatol 16 (4) (2026) 103525]

Journal of Clinical and Experimental Hepatology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles